Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Croatia Czechia Denmark Estonia +10
  • Study of elacestrant and exemestane treatment for patients with previously treated hormone receptor-positive, HER2-negative metastatic breast cancer with FES-avid lesions

    Recruiting

    2 1 1 1
    Italy
  • Study of momelotinib in patients with VEXAS syndrome and myelodysplastic syndrome who are dependent on or do not respond to steroid treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    France
  • Comparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery

    Recruiting

    2 1 1
    Investigated Drugs:
    Bulgaria Czechia Hungary Latvia Lithuania Poland
  • Study of RSV vaccine immune response persistence and revaccination safety in adult lung and kidney transplant recipients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Germany Italy Spain
  • Study of lidocaine with epinephrine and sodium bicarbonate compared to lidocaine with epinephrine alone for local anesthesia in hand and foot surgery patients

    Recruiting

    3 1 1
    France
  • Study of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer

    Recruiting

    4 1 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Greece +5
  • Study of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing

    Recruiting

    3 1 1 1
    Belgium France Greece Ireland Italy Poland +1
  • Study of MK-5684 compared to standard therapy in patients with breast cancer, ovarian cancer, or endometrial cancer

    Recruiting

    4 1 1 1
    Spain
  • Study of ONO-4578 and nivolumab with drug combination for first-line treatment in patients with PD-L1 positive advanced colorectal cancer

    Recruiting

    2 1 1 1
    France Italy Spain